I think everyone here and then some, couldn't agree more. The response to EPADI CP was very disturbing. 'It's complicated' nothing complicated about, EPA ability to neutralize/reduce soft plaque, which would prevent/reduce eruptions (break-offs, is validated. I am in a higher then normal risk, I think Vascepa should be used in for lower risk CV patiants ,risk prevention. A proactive use rather than reactive.
The FDA's actions, are an insult to intelligent Americans!